Feasibility study of weekly paclitaxel plus gemcitabine for metastatic and recurrent breast cancer with negative HER2
Not Applicable
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000007445
- Lead Sponsor
- Kyushu Breast Cancer Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Allergy to clemohol EL 2.Significant interstitial pneumonia or pulmonary fibrosis seen by chest radiograph and presence of symptoms associated with them 3.Pregnant or lactation women, or women with suspected pregnancy 4.Symptomatic CNS metastasis 5.Infection which needs treatment 6.Poorly controlled pleural effusion or peritoneal effusion 7.Patients judged by the investigator to be unfit for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate, safety
- Secondary Outcome Measures
Name Time Method response duration, time to progression, overall survival